Quintiles Company: Overview and Background
Quintiles was a prominent healthcare services and data analytics company that focused on clinical development, commercial analytics, and technology solutions for the pharmaceutical and biotechnology industries. In 2016, Quintiles merged with IMS Health to form IQVIA, a global leader in health data science. Understanding quintiles company means understanding the foundation that powered much of modern clinical research and real-world evidence generation.
More from this site
Keep reading the latest coverage
What Quintiles Did
Quintiles operated across several core areas within the healthcare ecosystem:
- Clinical trial services and management
- Biostatistics and data analytics
- Regulatory support and consulting
- Real-world evidence and outcomes research
- Technology platforms for data integration
The company helped pharmaceutical firms design, run, and analyze clinical trials more efficiently. It also supported health authorities and payers by turning large datasets into actionable insights about drug safety, effectiveness, and market trends.
History and Growth
Quintiles was founded in 1982 and grew rapidly by positioning itself at the intersection of healthcare and information technology. Over the decades, it expanded globally, acquiring firms and building proprietary data assets. Its scale made it a trusted partner for some of the largest drug developers and health systems worldwide.
The Quintiles Merger and Formation of IQVIA
The 2016 merger of Quintiles and IMS Health created IQVIA, combining Quintiles' clinical and analytics expertise with IMS Health's data collection and market intelligence strengths. Today, IQVIA operates with a much broader footprint, but many of the capabilities historically associated with quintiles company remain central to its identity.
Why Quintiles Mattered
Quintiles played a significant role in accelerating drug development timelines and improving the quality of evidence used in regulatory decisions. By standardizing data collection and applying advanced analytics, the company helped reduce uncertainty in clinical programs and supported faster access to new therapies.
Services and Capabilities
Key services historically offered by Quintiles included:
- End-to-end clinical trial management
- Adaptive trial designs and statistical modeling
- Patient recruitment and engagement solutions
- Safety surveillance and pharmacovigilance
- Commercial analytics for market access
Industry Impact
The influence of quintiles company extended beyond its own operations. It helped shape industry standards for data quality, transparency, and the use of real-world evidence in regulatory submissions. Many practices now considered standard in clinical research were advanced or formalized through work led by Quintiles.
Legacy and Current Relevance
While the Quintiles name no longer exists as a standalone entity, its legacy persists through IQVIA and the many professionals, systems, and processes it established. Organizations still reference quintiles company when discussing the evolution of healthcare data science and the modernization of clinical development.